In8bio Inc Stock Price Patterns
| INAB Stock | USD 1.91 -0.08 -4.02% |
Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.78 | EPS Estimate Current Year -3.22 | EPS Estimate Next Year -1.72 | Wall Street Target Price 6.25 | EPS Estimate Current Quarter -1.25 |
This view frames how In8bio Inc responds to recent headlines and peer activity within its market context.
This sentiment view summarizes headline intensity and market attention around In8bio to frame short-term volatility context.
In8bio after-hype prediction price | $ 1.98 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use In8bio Basic Forecasting Models to cross-verify projections for In8bio. The models provide an additional statistical reference.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of In8bio's price to converge to an average value over time is called mean reversion.
In8bio After-Hype Price Density Analysis
As far as predicting the price of In8bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
In8bio Estimiated After-Hype Price Volatility
In the context of predicting In8bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on In8bio's historical news coverage.
Current Value
The after-hype framework applied to In8bio Inc assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
In8bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as In8bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with In8bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 6.84 | 0.03 | 0.03 | 7 Events | 6 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.91 | 1.98 | 1.49 |
|
In8bio Hype Timeline
In8bio Inc is currently traded for 1.91. The company has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.03. In8bio is forecasted to decline in value after the next headline, with the price expected to drop to 1.98. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.49%, whereas the daily expected return is currently at 0.43%. The volatility of related hype on In8bio is about 8769.23%, with the expected price after the next announcement by competition of 1.94. About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.38. Some equities with similar Price to Book (P/B) outperform the market in the long run. In8bio Inc recorded a loss per share of 5.26. The company had not issued any dividends in recent years. The firm completed a 1:30 stock split on 6th of June 2025. Given the investment horizon of 90 days the next forecasted press release will be in 7 days. Use In8bio Basic Forecasting Models to cross-verify projections for In8bio. The models provide an additional statistical reference.In8bio Related Hype Analysis
Having access to credible news sources related to In8bio's direct competition is more important than ever and may enhance your ability to predict In8bio's future price movements. Getting to know how In8bio's peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RNAZ | Transcode Therapeutics | 0.57 | 6 per month | 4.91 | 0.06 | 16.20 | -7.47 | 35.66 | |
| APVO | Aptevo Therapeutics | -0.59 | 6 per month | 0.00 | -0.32 | 6.56 | -11.40 | 40.48 | |
| HCWB | HCW Biologics | 0.1 | 6 per month | 0.00 | -0.26 | 8.11 | -11.97 | 42.74 | |
| LYRA | Lyra Therapeutics | 0.03 | 3 per month | 0.00 | -0.15 | 13.48 | -15.12 | 53.33 | |
| KPRX | Kiora Pharmaceuticals | -0.02 | 4 per month | 2.48 | 0.02 | 3.96 | -3.90 | 12.37 | |
| GLTO | Galecto | 1.12 | 8 per month | 7.02 | 0.11 | 14.48 | -12.23 | 45.55 | |
| APRE | Aprea Therapeutics | -0.17 | 10 per month | 0.00 | -0.02 | 11.29 | -8.43 | 46.26 | |
| ACXP | Acurx Pharmaceuticals LLC | -0.10 | 6 per month | 4.29 | 0.11 | 38.01 | -8.54 | 49.19 | |
| BCDA | Biocardia | -0.11 | 7 per month | 0.00 | -0.03 | 5.98 | -6.30 | 20.06 | |
| PHIO | Phio Pharmaceuticals Corp | -0.05 | 9 per month | 5.79 | 0.02 | 13.86 | -10.53 | 56.33 |
In8bio Additional Predictive Modules
Most predictive techniques to examine In8bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for In8bio using various technical indicators. When you analyze In8bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About In8bio Sentiment
Sentiment analysis for In8bio evaluates news tone, positioning, and narrative momentum. Market-sensitive characteristics amplify cycle exposure. In8bio has a market cap of 19.43 M, ROE of -1.9%. 
Ellen Johnson · Member of Macroaxis Editorial Board
Unless otherwise specified, financial data for In8bio Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Updates may occur throughout the day.
In8bio Stock is Curated By:
Ellen Johnson · Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for In8bio Stock analysis
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |